Autoimmune complications of COVID‐19

DOI Web Site Web Site 被引用文献2件
  • Niloufar Yazdanpanah
    Research Center for Immunodeficiencies, Children's Medical Center Tehran University of Medical Sciences Tehran Iran
  • Nima Rezaei
    Research Center for Immunodeficiencies, Children's Medical Center Tehran University of Medical Sciences Tehran Iran

抄録

<jats:title>Abstract</jats:title><jats:p>Coronavirus disease 2019 (COVID‐19) is still propagating a year after the start of the pandemic. Besides the complications patients face during the COVID‐19 disease period, there is an accumulating body of evidence concerning the late‐onset complications of COVID‐19, of which autoimmune manifestations have attracted remarkable attention from the first months of the pandemic. Autoimmune hemolytic anemia, immune thrombocytopenic purpura, autoimmune thyroid diseases, Kawasaki disease, Guillain‐Barre syndrome, and the detection of autoantibodies are the cues to the discovery of the potential of COVID‐19 in inducing autoimmunity. Clarification of the pathophysiology of COVID‐19 injuries to the host, whether it is direct viral injury or autoimmunity, could help to develop appropriate treatment.</jats:p>

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ